A Cluster of Trace-Concentration Methamphetamine Identifications in Racehorses Associated with a Methamphetamine-Contaminated Horse Trailer: A Report and Analysis by Brewer, Kimberly et al.
University of Kentucky 
UKnowledge 
Gluck Equine Research Center Faculty 
Publications Gluck Equine Research Center 
8-2016 
A Cluster of Trace-Concentration Methamphetamine 
Identifications in Racehorses Associated with a 
Methamphetamine-Contaminated Horse Trailer: A Report and 
Analysis 
Kimberly Brewer 
Theodore F. Shults 
American Association of Medical Review Officers 
Jacob Machin 
University of Kentucky 
Sucheta Kudrimoti 
University of Kentucky 
Rodney L. Eisenberg 
Frontier BioPharm 
See next page for additional authors 
ollow this and additional works at: https://uknowledge.uky.edu/gerc_facpub 
 Part of th  Large or Food Animal and Equine Medicine Commons 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Repository Citation 
Brewer, Kimberly; Shults, Theodore F.; Machin, Jacob; Kudrimoti, Sucheta; Eisenberg, Rodney L.; Hartman, 
Petra; Wang, Caroline; Fenger, Clara; Beaumier, Pierre; and Tobin, Thomas, "A Cluster of Trace-
Concentration Methamphetamine Identifications in Racehorses Associated with a Methamphetamine-
Contaminated Horse Trailer: A Report and Analysis" (2016). Gluck Equine Research Center Faculty 
Publications. 26. 
https://uknowledge.uky.edu/gerc_facpub/26 
This Article is brought to you for free and open access by the Gluck Equine Research Center at UKnowledge. It has 
been accepted for inclusion in Gluck Equine Research Center Faculty Publications by an authorized administrator of 
UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu. 
A Cluster of Trace-Concentration Methamphetamine Identifications in 
Racehorses Associated with a Methamphetamine-Contaminated Horse Trailer: A 
Report and Analysis 
Abstract 
Three low concentration methamphetamine “positive” tests were linked to use of a methamphetamine-
contaminated trailer to transport the affected horses. This incident establishes methamphetamine as a 
human-use substance that can inadvertently enter the environment of racing horses, resulting in urinary 
methamphetamine “positives;” an interim regulatory cut-off of 15 ng/mL for methamphetamine in post-
race urine is proposed. 
Keywords 
methamphetamine identifications, racehorses, contamination 
Disciplines 
Large or Food Animal and Equine Medicine 
Notes/Citation Information 
Published in The Canadian Veterinary Journal, v. 57, p. 860-864. 
The publisher has granted the permission for posting the article here. 
Use of this article is limited to a single copy for personal study. Anyone interested in obtaining reprints 
should contact the CVMA office (hbroughton@cvma-acmv.org) for additional copies or permission to use 
this material elsewhere. 
Authors 
Kimberly Brewer, Theodore F. Shults, Jacob Machin, Sucheta Kudrimoti, Rodney L. Eisenberg, Petra 
Hartman, Caroline Wang, Clara Fenger, Pierre Beaumier, and Thomas Tobin 
This article is available at UKnowledge: https://uknowledge.uky.edu/gerc_facpub/26 
860 CVJ / VOL 57 / AUGUST 2016
Case Report Rapport de cas
A cluster of trace-concentration methamphetamine identifications in 
racehorses associated with a methamphetamine-contaminated horse 
trailer: A report and analysis
Kimberly Brewer, Theodore F. Shults, Jacob Machin, Sucheta Kudrimoti, Rodney L. Eisenberg,  
Petra Hartman, Caroline Wang, Clara Fenger, Pierre Beaumier, Thomas Tobin
Abstract — Three low concentration methamphetamine “positive” tests were linked to use of a methamphetamine-
contaminated trailer to transport the affected horses. This incident establishes methamphetamine as a human-use 
substance that can inadvertently enter the environment of racing horses, resulting in urinary methamphetamine 
“positives;” an interim regulatory cut-off of 15 ng/mL for methamphetamine in post-race urine is proposed.
Résumé — Identifications de concentrations de méthamphétamine à l’état de traces chez des chevaux de 
course associées à une remorque contaminée : rapport et analyse. Trois tests «positifs» de faibles concentrations 
de méthamphétamine ont été associés à l’utilisation d’une remorque contaminée par les méthamphétamines qui 
était utilisée pour transporter les chevaux affectés. Cet incident établit la méthamphétamine comme une substance 
à utilisation humaine qui peut pénétrer par inadvertance dans le milieu des chevaux de course, entainant ainsi des 
tests d’urine «positifs»; un niveau intérimaire réglementaire de 15 ng/mL pour les méthamphétamines est proposé 
pour les tests d’urine après la course.
(Traduit par Isabelle Vallières)
Can Vet J 2016;57:860–864
Introduction
M ethamphetamine (N-methyl-1-phenylpropan-2-amine, C10H15N, molecular mass 149.2) is a phenylethylamine 
central nervous system stimulant and a Schedule I controlled 
substance in Canada. Methamphetamine exists as 2 enantio-
mers, d-methamphetamine and l-methamphetamine (Figure 1). 
d-methamphetamine is the more pharmacologically active 
enantiomer and is a DEA Schedule II controlled substance 
in the United States. In the US, d-methamphetamine is FDA 
approved for human use and is available as Desoxyn for the 
treatment of Attention Deficit Hyperactivity Disorder (ADHD) 
and other conditions. l-methamphetamine is available in the 
US in “over-the-counter” decongestant products such as Vicks 
Vapoinhaler, in which the l-methamphetamine is identified as 
“levmetamfetamine.”
Racing laboratories now use Liquid Chromatography-Tandem 
Mass Spectrometry (LC/MS/MS) to test for methamphetamine. 
This has led to more than a thousand-fold increase in the 
sensitivity of testing compared with traditional enzyme-linked 
immunosorbent assay (ELISA) testing and the identification of 
trace level concentrations of substances (such as methamphet-
amine) that would not previously have been identified. While 
these trace level identifications are pharmacologically insignifi-
cant, they may be reported as “positives” under “zero tolerance” 
regulatory guidelines required of racing chemists.
Methamphetamine is also illegally synthesized and may 
be widely available as a “street” drug of uncertain purity and 
enantiomeric (d/l) composition. The drug is produced in illicit 
synthesis laboratories that are kept undercover, and a large horse 
trailer would be well-suited to a mobile covert laboratory.
We now report an incident in which a recently purchased 
horse trailer contaminated with methamphetamine yielded a 
cluster of 3 trace-concentration post-race urinary methamphet-
amine identifications within a 48-hour period. The trainer’s 
only other horse was transported in a different trailer and tested 
negative.
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The contaminated trailer was purchased by the horse trainer 
a few days prior to using it to ship horses on October 12th 
from Michigan to the 2014 Ajax Downs Quarter Horse Racing 
meet in Toronto. First contact of the affected horses with the 
 methamphetamine-contaminated trailer was when they were 
loaded into the trailer for transportation to Toronto. The 
journey took 6 h, following which the horses were stabled in 
the Toronto area and transported to race at Ajax Downs on 
October 13th and 14th. The 3 horses that were transported in 
the newly purchased trailer raced successfully and were post-
race tested, 2 on October 13 and 1 on October 14 (Table 1). 
Horse #1 won a maiden race on October 13th and tested posi-
tive for methamphetamine at 0.2 ng/mL. Horse #2 ran second 
on October 13th and tested positive at 0.056 ng/mL. Horse #3 
won a starter allowance on October 14th and tested positive 
at 0.34 ng/mL. Horse #4 was transported from Michigan to 
Toronto in a different trailer. This horse raced and was tested on 
October 13th and did not test positive for methamphetamine 
or any other substance.
The samples were called methamphetamine “positive” in post-
race urine tests performed by the official Canadian Laboratory, 
Maxxam Analytics of Burnaby, British Columbia. The referee 
split sample analyses were performed by Industrial Laboratories, 
Denver, Colorado, which confirmed the identifications and 
quantified the amounts present. The analytical methodologies 
available at that time in either laboratory did not distinguish 
between the d- and l-enantiomers of methamphetamine; how-
ever, more recent work at Industrial Laboratories has confirmed 
that the methamphetamine was present predominantly as the 
d form. No information is available concerning the presence of 
metabolites of methamphetamine — principally amphetamine 
— presumably because such information was not required 
and/or requested.
Laboratory testing for methamphetamine
In the United States, federal workplace testing identification 
of 80% or more l-methamphetamine suggests over-the-counter 
drug use, versus lower levels, which suggests illicit drug use (1,2). 
Also, the United States federal workplace testing protocol of the 
Substance Abuse and Mental Health Services Administration 
(SAMHSA) requires that methamphetamine/amphetamine be 
present in urine at . 500 ng/mL by immunological testing and 
that methamphetamine be confirmed by mass spectrometry at 
. 250 ng/mL, followed by confirmation of the metabolite, 
amphetamine, at a concentration . 100 ng/mL before a positive 
methamphetamine report may be issued (3).
This compares to the cut-offs suggested in “The Canadian 
Model for Providing a Safe Workplace: Drug and Alcohol 
Guidelines and Work Rule v5.0” of 500 ng/mL for total 
amphetamines (including d-/l-methamphetamine), with veri-
fication via GC-MS having a cut-off of 250 ng/mL for specific 
compounds (4). While these suggested levels are cutoffs recom-
mended by a professional organization of construction workers, 
their levels seem to match SAMHSA, and indicate similar levels 
are likely in Canada.
Scientific literature yields numerous reports showing that 
methamphetamine persists in the environment and in wastewa-
ter (5,6). These findings speak to inconsequential levels associ-
ated with of both licit and illicit human use in the environment, 
and also demonstrate its ability to persist in the environment 
(6,7), consistent with the presence in the contaminated trailer 
in the current matter.
The close spatial and temporal clustering of these 3 trace-
concentration, methamphetamine identifications is an extremely 
unusual event, both in the long time professional experience of 
the involved trainer, and in the scope of the human and equine 
drug testing experience of the authors. In particular, the trainer 
in question in this matter was in good standing with the Ontario 
Racing Commission (ORC). Furthermore, it is also extremely 
unusual to see 3 very low/trace concentration ARCI class 1 
substance identifications occurring in a small group of horses 
within a 48-hour period.
The ORC personnel investigating this matter also recognized 
the unusual nature of this cluster of methamphetamine identi-
fications. Following a series of interviews with the trainer and 
her staff, and considering the overall circumstances of this mat-
ter, the ORC investigators elected to take a number of samples 
from the trailer in which the horses in question were transported 
from Michigan to Toronto for methamphetamine testing, with 
a particular focus on the manger areas of the trailer.
Analysis of these trailer samples showed that at least 1 of 
these samples taken from the manger area of the trailer tested 
positive for methamphetamine at a concentration of 22 ng/g, or 
22 parts per billion. This positive finding for methamphetamine 
Figure 1. Methamphetamine, N-methyl-1-phenylpropan-2-amine exists as 2 enantiomers, 
d-methamphetamine and l-methamphetamine. d-Methamphetamine, the more active pharmaceutical, 
is a US DEA Schedule II controlled substance, while l-methamphetamine is available in over-the-counter 
preparations such as Vicks Vapoinhaler.
NH NH
CH3 CH3
CH3CH3
d-methamphetamine
dextro-methamphetamine
S(2)-methamphetamine
l-methamphetamine
levo-methamphetamine
R(1)-methamphetamine
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in the trailer is entirely consistent with the underlying cause of 
this cluster of trace urinary concentration methamphetamine 
identifications being this trailer’s contamination by metham-
phetamine, since the horses spent 6 h in the contaminated trailer 
during their journey from Michigan to Toronto while being 
shipped to Ajax Downs.
These interpretations were also recognized by the lead ORC 
investigator, who testified at the Stewards hearing that the 
methamphetamine identifications were apparently the result of 
inadvertent exposure of the horses to the contaminated trailer 
and that the identifications did not in any way reflect on the 
trainer involved.
The scientific literature on methamphetamine in the horse sup-
ports the ORC investigators analysis and interpretations. Work by 
Ray et al (8) shows that after IM administration of 150 mg meth-
amphetamine to horses the urinary concentrations of metham-
phetamine peak at a mean of about 7400 ng/mL (range: 3240 to 
17 930 ng/mL) at 4 h post-administration and thereafter decline. 
The urinary concentrations of methamphetamine reported in 
the current matter are between 20 000 and 130 000 times lower 
(0.34 and 0.056 ng/mL samples, respectively) than the mean 
peak urinary concentration reported by Ray et al (8) after their 
methamphetamine administrations.
A second conclusion that may be drawn from the trace con-
centrations of methamphetamine observed in these samples is 
that the amounts of methamphetamine present in the urine 
samples of these animals are 105 of the concentration which 
would be consistent with production of a pharmacological 
effect (8). As such, it is a reasonable conclusion that there 
was no effect on the racing performance of the horses in 
question.
The identification of trace level concentrations of human-
use substances in the post-race urine samples of racing horses 
is a not an uncommon occurrence. Beginning in the 1990s, 
the ongoing increases in the sensitivity of drug and medication 
testing in racehorses has created a need to develop regulatory 
thresholds/cut-offs for Endogenous, Dietary and Environmental 
substances (EDEs) in post-race urine samples (2,9).
Establishing regulatory cut-offs (thresholds)
The first trace environmental substance to come to the 
attention of racing regulators was caffeine, and Florida rac-
ing regulators introduced a plasma regulatory threshold of 
100 ng/mL, a cut-off since adopted by the Association of Racing 
Commissioners International (ARCI) and now in place in at 
least 10 US jurisdictions. In Florida, this threshold has since 
been adjusted to 200 ng/mL in urine (10).
Another environmental substance regulatory cut-off used in 
several states is for benzoylecgonine (BZE), the major urinary 
metabolite of cocaine, which is efficiently excreted at relatively 
high concentrations in equine urine. Like caffeine, cocaine is 
widespread in the human environment and is found in mea-
surable quantities on about 80% of paper money in the US. 
Though exposure to the quantity of cocaine on paper money 
is generally insufficient to produce a pharmacological effect, 
ingestion by a horse of an amount of cocaine not uncommonly 
found on a single dollar bill in general circulation can produce 
a measurable concentration of BZE in the horse’s urine — a 
potential positive test (11).
One outcome of the widespread environmental presence of 
trace amounts of cocaine is that US Department of Health and 
Human Services human workplace drug testing has a BZE uri-
nary screening “cut-off ” of 150 ng/mL and a confirmation cut-
off of 100 ng/mL (12). This threshold was essentially adopted 
by a number of racing commissions, and equine urinary BZE 
thresholds are in place in at least 7 US racing jurisdictions rang-
ing from 50 to 150 ng/mL (2,11).
Morphine is also an ARCI class 1 substance that is occasion-
ally identified in post-race equine urine samples, usually as 
classic clusters associated with inadvertent feed contamination, 
although isolated cases occur in which the source of the mor-
phine remains unidentified. Again, the solution to this problem 
has been the introduction of equine urinary cut-offs varying 
from 50 to 120 ng/mL depending on the jurisdiction involved 
(2,12,13). These equine urinary cut-offs are considerably more 
rigorous than the 2000 ng/mL opiate cut-off used in US 
Department of Health and Human Services human workplace 
drug testing (3).
Consistent with the above referenced well-established regula-
tory cut-offs for environmental substances, it is now apparent 
that the increased sensitivity of testing for methamphetamine 
has created a need for its own regulatory cut-off in equine test-
ing. In the absence of a defined regulatory cut-off, “positives” 
are reported down to the limit of detection of the analytical 
method. The sensitivity of testing for methamphetamine in 
this current matter, at a limit of detection of about 0.05 ng/mL 
(50 pg/mL), is 1000 times less concentrated than the cut-offs 
for caffeine, benzoylecgonine, and morphine in post-race urine 
samples, and 10 000 times less than the 500 ng/mL amphet-
amine screening human cut-off of the US Department of Health 
Table 1. Transportation, racing and urinary methamphetamine analytical data on 4 horses transported to Ajax Downs, 
Toronto, Ontario, for racing on October 13 and 14, 2014
     Time in Sample Split sample
 Race date  Race  trailer A (Maxxam lab (Industrial lab
Horse (2014) Race type result Trailer (hours) test result) test result)
Fames Winner Oct 13 Maiden Win A 61 Positive 0.20 ng/mL
Chasing Royalty Oct 13 Allowance Place A 61 Positive 0.056 ng/mL
JJ Maxwell Oct 14 Starter Allowance Win A 61 Positive 0.34 ng/mL
Jess What To Wear Oct 13 Allowance — non  Win B 0 Negative N/A 
  winner of two
The Maxxam laboratory and Industrial laboratories tested split samples. N/A — Not available.
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and Human Services (3). The only question that remains is to 
determine precisely what the appropriate concentration for this 
urinary methamphetamine cut-off should be. Review of data 
generated by Ray et al (8), which showed a mean peak urinary 
concentration of methamphetamine of 7400 ng/mL following 
administration of a 150 mg dose of methamphetamine, suggests 
that a 1000-fold lower urinary methamphetamine concentra-
tion, as seen in the cluster of horses in question, is unlikely to 
be associated with a pharmacological effect. Therefore, a urinary 
methamphetamine concentration of , 15 ng/mL in urine would 
be unlikely to be associated with any possible effect on a horse at 
the time of racing, and as such would be an appropriate interim 
environmental cut-off for methamphetamine identifications in 
post-race urines.
With respect to developing an environmental substance 
threshold or cut-off for methamphetamine in post-race urine 
samples, it may be instructive to consider the protocol used in 
US Department of Health and Human Services human work-
place drug testing for methamphetamine. To report a urine 
sample positive for methamphetamine the sample must first 
yield an initial immunoassay result of more than 500 ng/mL for 
combined amphetamine/methamphetamine reactivity, then the 
laboratory must confirm by Mass Spectrometry that the sample 
contains more than 250 ng/mL of methamphetamine and also 
that the sample contains at least 100 ng/mL of the metabolite, 
amphetamine. This is to show that the methamphetamine has 
actually passed through the individual in question. This pre-
caution is required as early GC/MS confirmation procedures 
used in human drug testing were shown to convert ephedrine 
to methamphetamine and it was necessary to rule out analytical 
neogenesis of methamphetamine from ephedrine.
It is well-established that individuals living in or exposed to 
clandestine methamphetamine laboratories become contami-
nated with methamphetamine and will test positive for meth-
amphetamine at much higher concentrations than is required 
for human workplace positive identifications. These positives 
occur not because they are actively using the drug, but simply 
from environmental exposure; this is best seen with regard to 
toxicology studies on children and infants found living in places 
where methamphetamine is being manufactured, according to a 
Department of Justice review (14). With regard to the difficulty 
of removing methamphetamine residues from such an environ-
ment, this report notes that “Normal cleaning will not remove 
methamphetamine and some of the chemicals used to produce it. 
They may remain on eating and cooking utensils, floors, countertops, 
and absorbent materials. Toxic by-products of meth manufacturing 
are often improperly disposed outdoors, endangering children and 
others who live, eat, play, or walk at or near the site” (14). One 
author (TFS) has recommended that first-responders and police 
officers be screened both before and after their exposure to drug 
laboratories or drug storage facilities.
Methamphetamine, a substance of human use/abuse, can 
inadvertently become part of the environment of racing horses, 
yielding trace urinary methamphetamine “positives” in post-
race testing. As such, there is a need to establish a cut-off or 
threshold for methamphetamine in equine drug testing, as has 
been done for other environmental substances (caffeine, BZE, 
morphine, etc.) to avoid unjustly penalizing the connections of 
the horse and tarnishing the image of racing. We therefore sug-
gest an interim urinary threshold/cut-off for methamphetamine 
of at least 15 ng/mL, similar to thresholds already established for 
other environmental substances, and well below the 500 ng/mL 
cut-off used by the US Department of Health and Human 
Services in human workplace drug testing. This interim thresh-
old would be appropriate prima facie until a review leads to a 
formal regulatory decision to establish a threshold that takes into 
account metabolite concentrations and effects of other variables, 
such as urine pH, on racehorse sample concentrations. While it 
may need to be raised or lowered in the future, 15 ng/mL is at 
this time a conservative estimate based upon the current findings 
in the case presented.
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Note:
In Ontario, these matters went to a Steward’s hearing on 
October 23rd, 2014; despite the weight of evidence for 
trainer innocence, the trainer was fined $5000 and suspended 
for 1 year. The matter was appealed to the Ontario Racing 
Commission (ORC), which held hearings related to this matter 
in July to September 2015. On February 8th, 2016 the ORC 
allowed the appeals and set aside the Steward’s penalties. The 
ORC noted the substantial increases in sensitivity of equine drug 
testing, consistent with the very low levels of methamphetamine 
identified in these horse urines, levels in the opinion of the ORC 
with no possible impact on the performance, health and safety 
of horses, and levels consistent with inadvertent environmental 
contamination. The ORC also noted the need “to set limits high 
enough to cut-off the environmental noise and low enough to stop 
performance enhancement.” In this communication we have pre-
sented our best estimate of this as 15 ng/mL interim regulatory 
cut-off for methamphetamine in post-race horse urine.
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